Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Hepatology

• Publication date

  2010-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.23240PMID 19839063
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C

  2008cited by this paper
• The natural history of recurrent hepatitis C and what influences this

  2008cited by this paper
• Acute viral hepatitis increases liver stiffness values measured by transient elastography

  2008cited by this paper
• Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation

  2008cited by this paper
• Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease

  2008cited by this paper
• How accurately and how early can we predict rapid fibrosis progression in hepatitis C virus–infected patients after liver transplantation?

  2008cited by this paper
• Assessment of Graft Fibrosis by Transient Elastography in Patients With Recurrent Hepatitis C After Living Donor Liver Transplantation

  2008cited by this paper
• Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

  2007cited by this paper
• Acute viral hepatitis increases liver stiffness values measured by transient elastography

  2007cited by this paper
• Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation

  2007cited by this paper
• Meta-analyses of FibroTest diagnostic value in chronic liver disease

  2007cited by this paper
• Liver biopsy assessment in chronic viral hepatitis: a personal, practical approach

  2007cited by this paper
• Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis

  2007cited by this paper
• Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage

  2007cited by this paper
• Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.

  2007cited by this paper
• Diagnostic accuracy of the aspartate aminotransferase‐to‐platelet ratio index for the prediction of hepatitis C–related fibrosis: A systematic review

  2007cited by this paper
• Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis

  2007cited by this paper
• Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation

  2006cited by this paper
• Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC

  2006cited by this paper
• Prospective Comparison of Transient Elastography, Fibrotest, APRI, and Liver Biopsy for the Assessment of Fibrosis in Chronic Hepatitis C

  2006cited by this paper
• Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation

  2006cited by this paper
• Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

  2005cited by this paper
• Prediction of fibrosis in HCV‐infected liver transplant recipients with a simple noninvasive index

  2005cited by this paper
• Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C

  2005cited by this paper
• Sources of variability in histological scoring of chronic viral hepatitis

  2005cited by this paper
• Peginterferon alfa‐2a for hepatitis C after liver transplantation: Two randomized, controlled trials

  2005cited by this paper
• Serum markers detect the presence of liver fibrosis: a cohort study.

  2004cited by this paper
• Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

  2004cited by this paper
• Prevention and treatment of hepatitis C virus recurrence after liver transplantation.

  2004cited by this paper
• Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation

  2004influential reference
• Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

  2003cited by this paper
• Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

  2003cited by this paper
• Sampling variability of liver fibrosis in chronic hepatitis C

  2003cited by this paper
• The association between hepatitis C infection and survival after orthotopic liver transplantation.

  2002cited by this paper
• Contribution of donor age to the recent decrease in patient survival among HCV‐infected liver transplant recipients

  2002cited by this paper
• Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft.

  2002cited by this paper
• Hepatitis C virus kinetics during and immediately after liver transplantation

  2002influential reference
• Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C

  2002cited by this paper
• HCV-related fibrosis progression following liver transplantation: increase in recent years.

  2000cited by this paper
• High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes

  1999influential reference
• Hepatitis C

  1998cited by this paper
• The nomenclature of chronic hepatitis: time for a change.

  1995cited by this paper

• Can elastography predict early allograft dysfunction or loss after liver transplantation? A prospective study of diagnostic accuracy

  2025cites this paper
• A Diagnostic Biomarker Model for Chronic Fibrosis After Liver Transplantation

  2025cites this paper
• Sustained virological response in chronic hepatitis C patients by direct-acting antiviral treatment significantly reduces liver stiffness over 24 weeks posttreatment

  2024cites this paper
• Changes in graft density after effective treatment of recurrent hepatitis C in liver transplant recipients during long-term follow-up

  2024cites this paper
• Managing HBV and HCV Infection Pre- and Post-liver Transplant.

  2023cites this paper
• Fibroblast‐specific adipocyte enhancer binding protein 1 is a potential pathological trigger and prognostic marker for liver fibrosis independent of etiology

  2023cites this paper
• Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection

  2022cites this paper
• Management of Transplant Patients Infected with HCV

  2021cites this paper
• Clinical Practice Guidelines for Liver Transplantation in Saudi Arabia

  2021cites this paper
• Elastography in Liver-Transplanted Patients

  2021cites this paper
• A Diagnostic Test Meta‐Analysis Evaluating Imaging‐Based and Blood Biomarker–Based Assessment Tools for Fibrosis After Liver Transplantation

  2021cites this paper
• Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?

  2021cites this paper
• NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATION.

  2021cites this paper
• Role of Liver Stiffness in the Management of Liver Transplantation: First Experience and Clinical Practice

  2020cites this paper
• Passive stiffness of fibrotic skeletal muscle in mdx mice relates to collagen architecture

  2020cites this paper
• Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection

  2019cites this paper
• Management of HCV Infection After Liver Transplantation

  2019cites this paper
• The impact of immunosuppressant therapy on the recurrence of hepatitis C post-liver transplantation

  2018cites this paper
• Diagnostic Methods for Cirrhosis and Portal Hypertension

  2018influential citation
• Predicting Fibrosis Progression in Renal Transplant Recipients Using Laser-Based Infrared Spectroscopic Imaging

  2018cites this paper
• Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk – an observational, retrospective study

  2018cites this paper
• Long‐term liver stiffness assessment in hepatitis C virus patients undergoing antiviral therapy: Results from a 5‐year cohort study

  2018cites this paper
• Change in liver stiffness measured by ARFI elastography after antiviral treatment in patients with relapse of HCV infection after liver transplantation

  2018cites this paper
• Spleen Stiffness by Ultrasound Elastography

  2018cites this paper
• Evaluation of acoustic radiation force impulse (ARFI) elastography as non-invasive diagnostic tool in living donor liver transplantation

  2018cites this paper
• 9 Hepatitis C and Liver Transplantation

  2017cites this paper
• A Metabolomics Signature Linked To Liver Fibrosis In The Serum Of Transplanted Hepatitis C Patients

  2017cites this paper
• Nuevos factores del hospedador en la fisiopatología y la respuesta al tratamiento antiviral de la infección por el virus de la hepatitis C

  2017cites this paper
• Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon

  2017cites this paper
• Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation

  2016cites this paper
• When and How to Treat HCV Infection with the New Antivirals before or after Liver Transplantation

  2016cites this paper
• Early non‐invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation

  2016cites this paper
• HCV Recurrence: Predictors and Outcomes After Liver Transplantation

  2016cites this paper
• EASL Clinical Practice Guidelines: Liver transplantation.

  2016cites this paper
• Simple prediction of long‐term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation

  2016cites this paper
• APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing

  2016cites this paper
• Liver transplantation for viral hepatitis in 2015.

  2016cites this paper
• Diagnostic Accuracy of Transient Elastography for Detecting Liver Fibrosis After Liver Trannsplantation: A Specific Cut-Off Value Is Really Needed?

  2016cites this paper
• Usefulness of liver stiffness measurement during acute cellular rejection in liver transplantation

  2016cites this paper
• New perspectives for preventing hepatitis C virus liver graft infection

  2016cites this paper
• Applicability and accuracy improvement of transient elastography using the M and XL probes by experienced operators

  2015cites this paper
• Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance

  2015cites this paper
• Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?

  2015cites this paper
• Valoración del antígeno del core como alternativa en el cribado rutinario y de urgencia del virus de la hepatitis C

  2015cites this paper
• EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis European Association for the Study of the Liver ⇑ , Asociación Latinoamericana para el Estudio del Hígado

  2015cites this paper
• Chapter 11 – Transplantation for Hepatitis C

  2015cites this paper
• Collagen crosslinking does not dictate stiffness in a transgenic mouse model of skeletal muscle fibrosis.

  2015cites this paper
• Non‐invasive diagnosis tests

  2015cites this paper
• EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.

  2015cites this paper
• Transient elastography（FibroScan）による肝硬度測定

  2015cites this paper
• Management of post transplant hepatitis C in the direct antiviral agents era

  2015cites this paper
• INFLUENCIA DE LOS POLIMORFISMOS GENÉTICOS DE LOS RECEPTORES "TOLL-LIKE" EN LA GRAVEDAD DE LA RECIDIVA VIRAL Y EN LA INCIDENCIA DEL RECHAZO AGUDO EN PACIENTES CON TRASPLANTE HEPÁTICO POR CIRROSIS POR EL VIRUS DE LA HEPATITIS C

  2014cites this paper
• Liver Stiffness 1 Year After Transplantation Predicts Clinical Outcomes in Patients With Recurrent Hepatitis C

  2014cites this paper
• Prediction of fibrosis progression in chronic viral hepatitis

  2014cites this paper
• Μanagement of patients with hepatitis B and C before and after liver and kidney transplantation.

  2014cites this paper
• Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

  2014cites this paper
• Impact of Acoustic Radiation Force Impulse Imaging in Clinical Practice of Patients after Orthotopic Liver Transplantation

  2014cites this paper
• Management of HCV transplant patients with triple therapy

  2014cites this paper
• Outcomes in liver transplantation: Does sex matter?

  2014cites this paper
• Hepatitis C recurrence: the Achilles heel of liver transplantation

  2014cites this paper
• A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.

  2014cites this paper
• Recurrent HCV after liver transplantation—mechanisms, assessment and therapy

  2014cites this paper
• Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation.

  2014cites this paper
• Evaluation of graft stiffness using acoustic radiation force impulse imaging after living donor liver transplantation

  2014cites this paper
• Management of recurrent hepatitis C virus after liver transplantation.

  2014cites this paper
• NATURAL COURSE AND TREATMENT OUTCOME IN HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION

  2014cites this paper
• Viral Hepatitis and Liver Transplantation: Pathogenesis, Prevention and Therapy of Recurrent Disease

  2014cites this paper
• Management of Chronic Hepatitis C in Cirrhosis and Liver Transplant Population

  2014cites this paper
• Optimal Management of HCV Transplant Patients

  2014cites this paper
• Risk factors and management of hepatitis C recurrence after liver transplantation

  2014cites this paper
• Diffusion weighted MRI and transient elastography assessment of liver fibrosis in hepatitis C patients: Validity of non invasive imaging techniques

  2014cites this paper
• The challenge of non-invasive evaluation of fibrosis after liver transplantation.

  2013cites this paper
• Staging of Hepatic Fibrosis: Comparison of Magnetic Resonance Elastography and Shear Wave Elastography in the Same Individuals

  2013cites this paper
• Non‐invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C

  2013cites this paper
• JSUM ultrasound elastography practice guidelines: liver

  2013cites this paper
• Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment.

  2013influential citation
• Recurrence of hepatitis C after liver transplantation

  2013cites this paper
• The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis

  2013cites this paper
• Shear wave elastography in the evaluation of rejection or recurrent hepatitis after liver transplantation

  2013cites this paper
• Current management and perspectives for HCV recurrence after liver transplantation

  2013cites this paper
• Non-invasive assessment of liver graft fibrosis by transient elastography after liver transplantation.

  2013cites this paper
• A study of novel biomarkers of hepatitis C related liver injury

  2013cites this paper
• [Histological lesions in the graft in patients with long-term survival after transplantation. Are protocol biopsies necessary?].

  2013cites this paper
• Clinical Application of Liver Stiffness Measurement Using Transient Elastography: A Surgical Perspective

  2013cites this paper
• Viral hepatitis in liver transplantation.

  2012cites this paper
• Hepatitis C virus treatment pre‐ and post‐liver transplantation

  2012cites this paper
• Assessing the Progression of Chronic HCV to Cirrhosis

  2012cites this paper
• Hepatic Transplant and HCV: A New Playground for an Old Virus

  2012cites this paper
• Post-transplant liver biopsy and the immune response: lessons for the clinician

  2012cites this paper
• Hepatic Elastography Using Ultrasound Waves

  2012cites this paper
• Non-invasive assessment of liver fibrosis

  2012cites this paper
• Monitoring the natural evolution and response to treatment of post liver transplant recurrent hepatitis C using transient elastography: preliminary results.

  2012cites this paper
• Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

  2012cites this paper
• Long‐Term Management of Recurrent Primary Liver Disease

  2012cites this paper
• [Serum markers of liver fibrosis in patients with chronic hepatitis C infection. Prognostic value of noninvasive markers of fibrosis in liver transplantation].

  2012cites this paper
• Liver transplantation in the setting of chronic HCV.

  2012cites this paper
• Evaluación de la fibrosis asociada a la enfermedad hepática

  2012cites this paper
• Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy

  2012cites this paper
• Liver Transplantation and Hepatitis C

  2012cites this paper
• APASL consensus statements and management algorithms for hepatitis C virus infection

  2012cites this paper